Navigation Links
Endocare and Galil Medical Announce Settlement of Litigation
Date:7/7/2009

IRVINE, Calif. and YOKNEAM, Israel, July 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO) and privately-held Galil Medical Ltd., today announced that they have entered into a settlement agreement stipulating to termination of the previously announced merger agreement between Endocare and Galil Medical pursuant to which Endocare would have acquired Galil Medical, and the settlement of all related litigation in Delaware Chancery Court.

About Endocare

Endocare, Inc.--www.endocare.com-- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).

About Galil Medical

Galil Medical is a global medical device company that develops, manufactures and markets innovative products utilizing a proprietary cryoablation platform that incorporates powerful freezing technology and revolutionary 17-gauge cryoablation needle design. The company has offices in Yokneam, Israel; Plymouth Meeting, Pennsylvania; and London. Shareholders include Thomas, McNerney & Partners, The Vertical Group, Investor Growth Capital, Elron Electronic Industries Ltd. (Nasdaq: ELRN) and RDC Rafael Development Corporation, Ltd.

    Investor Contact:
    Matt Clawson
    Allen & Caron, Inc.
    (949) 474-4300
    matt@allencaron.com

    Media Contact:

'/>"/>
SOURCE Endocare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Endocare Reports Financial Results for Third Quarter 2008
2. Endocare Reports 2008 First Quarter Financial Results
3. Advance Nanotechs Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo
4. Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
5. Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
6. Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
7. Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
8. Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
9. Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
10. 2009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care
11. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... Florida (PRWEB) April 23, 2015 ... it intends to conduct a groundbreaking pilot study ... to be reversed in as little as three ... science of metabolic and nutritional medicine—will aggressively target ... cripple and destroy our aging brain. These include ...
(Date:4/23/2015)... 2015 Six startups from Russia ... 4-17 as part of the U.S.-Russia Innovation Corridor ... of biotechnology startups to participate in the program ... and the University of Maryland (UMD) signed a ... respective universities in the biomedical industry in 2013. ...
(Date:4/23/2015)... 23, 2015 Follow us ... a series of genetic tests that determine individual ... Gehrig's disease, Huntington's disease, and Alzheimer's disease. Predictive ... composition and interaction in diseased tissue/cells to understand ... as the response to treatment, such as in ...
(Date:4/23/2015)... , April 23, 2015 ... Equipment   Report Details   We ... a value of $101.3 billion in 2015 and will grow ... growth in the healthcare sectors around the world and increasing ... key growth factors in the global healthcare packaging ...
Breaking Biology Technology:New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 4Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 2Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 3Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10
... in Second Half 2008, ANNAPOLIS, Md., Aug. ... biodefense company developing medical countermeasures,against biological and chemical ... second quarter and six months ended June 30,2008. ... -- Submitted response to a Request for ...
... More than 35% Compared to the previous Quarter ... Production Reaches 200,000 OmniPods per Month, BEDFORD, Mass., Aug. ... patch pump technology with its OmniPod(R),Insulin Management System, today announced ... 30, 2008., Second quarter 2008 reported revenue increased 131% ...
... Biosciences continues to,expand its offering of IRDye ... IRDye(R) 680 Donkey Anti-Chicken IgG, IRDye 800CW,Donkey ... and IRDye 800CW Goat,Anti-Rat IgG antibodies are ... for multiple applications including,quantitative Westerns, In-Cell Westerns, ...
Cached Biology Technology:PharmAthene Reports Second Quarter 2008 Financial and Operational Results 2PharmAthene Reports Second Quarter 2008 Financial and Operational Results 3PharmAthene Reports Second Quarter 2008 Financial and Operational Results 4PharmAthene Reports Second Quarter 2008 Financial and Operational Results 5PharmAthene Reports Second Quarter 2008 Financial and Operational Results 6PharmAthene Reports Second Quarter 2008 Financial and Operational Results 7PharmAthene Reports Second Quarter 2008 Financial and Operational Results 8Insulet Reports Second Quarter 2008 Results 2Insulet Reports Second Quarter 2008 Results 3Insulet Reports Second Quarter 2008 Results 4Insulet Reports Second Quarter 2008 Results 5Insulet Reports Second Quarter 2008 Results 6Insulet Reports Second Quarter 2008 Results 7Insulet Reports Second Quarter 2008 Results 8
(Date:4/8/2015)... CHARLOTTE, N.C. , April 8, 2015 /PRNewswire/ ... technology solutions and services, and Morpho, a leading ... in partnership to produce the market,s most advanced ... Infinisource,s iSolved NXG time clock is setting ... attendance and labor data for the small and ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... unique Mayo Clinic collaboration has revived the healing wisdom ... extract described in a 17th century Dutch herbal text ... from the Atun tree effectively control bacteria that can ... circa 1650. He documented his traditional healing methods in ...
... and Hispanic patients and those who are uninsured are less ... been associated with better outcomes, according to a study in ... improve the quality of surgical care in the United States ... hospitals for certain procedures, since a number of studies have ...
... experiments of their kind, researchers at Rice University and ... have determined that carbon nanotubes injected directly into the ... health effects and circulate for more than one hour ... findings are from the first in vivo animal study ...
Cached Biology News:Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug 2Minorities, uninsured less likely to receive care at high-volume hospitals 2Pure carbon nanotubes pass first in vivo test 2
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
GOAT ANTI PPP2R5B...
... Molecular Probes Fc OxyBURST Green reagent ... Simons of Boston University to permit measurement ... internalization and the subsequent oxidative burst directly ... assay reagent consists of bovine serum albumin ...
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
Biology Products: